文献速递淋巴瘤

原发性纵隔大B细胞淋巴瘤的综合基因组分析

Integrative genomic analysis identifies key pathogenic mechanisms in primary mediastinal large B-cell lymphoma.
PubMed 文献 · Blood · 2019-07-10

本研究对95例原发性纵隔大B细胞淋巴瘤(PMBL)肿瘤行全外显子测序,分析致癌驱动基因与复发性拷贝数改变,并结合基因表达特征。研究发现JAK-STAT与NF-κB通路高频致癌突变,免疫逃逸相关基因(CIITA、CD58、B2M、CD274、PDCD1LG2)及IRF通路成员(IRF2BP2、IRF4、IRF8)频繁改变。驱动基因在PMBL中突变频率显著高于弥漫大B细胞淋巴瘤,而与经典型霍奇金淋巴瘤仅少数基因显著不同。

要点

  • JAK-STAT与NF-κB通路存在高频致癌突变。
  • 免疫逃逸基因CIITA、CD58、B2M、CD274、PDCD1LG2改变提供免疫逃逸证据。
  • IRF通路(IRF2BP2、IRF4、IRF8)为多成员频繁改变的 putative 新标志。

核心结论

  • PMBL存在JAK-STAT、NF-κB通路高频突变及免疫逃逸相关改变,IRF通路为多成员频繁改变的 putative 新标志。
  • 驱动基因在PMBL中突变频率显著高于弥漫大B细胞淋巴瘤,仅少数基因在PMBL与经典型霍奇金淋巴瘤间显著不同。

研究设计与样本

  • 对95例PMBL肿瘤行全外显子测序,分析致癌驱动基因与复发性拷贝数改变,并整合体细胞突变与基因表达特征。

主要发现

  • JAK-STAT与NF-κB通路存在高频致癌突变。
  • CIITA、CD58、B2M、CD274、PDCD1LG2改变提供免疫逃逸在PMBL中重要性的额外证据。
  • IRF通路成员IRF2BP2、IRF4、IRF8频繁改变,为 putative 新标志。
  • 整合分析显示JAK1、RELB、EP300突变驱动致癌信号。
  • 鉴定出的驱动基因在PMBL中突变频率显著高于弥漫大B细胞淋巴瘤。

临床怎么用

  • 研究强调 distinctive 遗传改变对疾病分类的重要性,并涉及诊断评估与治疗决策。
  • JAK1、RELB、EP300突变驱动致癌信号,为潜在生物学依据。

局限性

  • 原文未述局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Primary mediastinal large B-cell lymphoma (PMBL) represents a clinically and pathologically distinct subtype of large B-cell lymphomas. Furthermore, molecular studies, including global gene expression profiling, have provided evidence that PMBL is more closely related to classical Hodgkin lymphoma (cHL). Although targeted sequencing studies have revealed a number of mutations involved in PMBL pathogenesis, a comprehensive description of disease-associated genetic alterations and perturbed pathways is still lacking. Here, we performed whole-exome sequencing of 95 PMBL tumors to inform on oncogenic driver genes and recurrent copy number alterations. The integration of somatic gene mutations with gene expression signatures provides further insights into genotype-phenotype interrelation in PMBL. We identified highly recurrent oncogenic mutations in the Janus kinase-signal transducer and activator of transcription and nuclear factor κB pathways, and provide additional evidence of the importance of immune evasion in PMBL (CIITA, CD58, B2M, CD274, and PDCD1LG2). Our analyses highlight the interferon response factor (IRF) pathway as a putative novel hallmark with frequent alterations in multiple pathway members (IRF2BP2, IRF4, and IRF8). In addition, our integrative analysis illustrates the importance of JAK1, RELB, and EP300 mutations driving oncogenic signaling. The identified driver genes were significantly more frequently mutated in PMBL compared with diffuse large B-cell lymphoma, whereas only a limited number of genes were significantly different between PMBL and cHL, emphasizing the close relation between these entities. Our study, performed on a large cohort of PMBL, highlights the importance of distinctive genetic alterations for disease taxonomy with relevance for diagnostic evaluation and therapeutic decision-making.

来源:Blood,查看原文。版权归原作者所有。

引用

  1. Mottok A, Hung SS, Chavez EA, et al. Integrative genomic analysis identifies key pathogenic mechanisms in primary mediastinal large B-cell lymphoma. Blood. 2019. PMID: 31292115. doi:10.1182/blood.2019001126

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。